Francesco Vacca

Dr. Francesco Vacca

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2020 in eLife
Verified
Journal Article
Open access
FVFrancesco Vacca
Francesco Vacca
CCCaroline Chauché
Caroline Chauché
AJAbhishek Jamwal
Abhishek Jamwal
EHElizabeth C Hinchy
Elizabeth C Hinchy
GHGraham Heieis
Graham Heieis
HMHenry McSorley
Henry McSorley
The IL-33-ST2 pathway is an important initiator of type 2 immune responses. We previously characterised the HpARI protein secreted by the model intestinal nematode Heligmosomoides polygyrus, which binds and blocks IL-33. Here, we identify H. polygyrus Binds Alarmin Receptor and Inhibits (HpBARI) and HpBARI_Hom2, both of which consist of complement control protein (CCP) domains, similarly to the immunomodulatory HpARI and Hp-TGM proteins. HpBARI binds murine ST2, inhibiting cell surface detection of ST2, preventing IL-33-ST2 interactions, and inhibiting IL-33 responses in vitro and in an in vivo mouse model of asthma. In H. polygyrus infection, ST2 detection is abrogated in the peritoneal cavity and lung, consistent with systemic effects of HpBARI. HpBARI_Hom2 also binds human ST2 with high affinity, and effectively blocks human PBMC responses to IL-33. Thus, we show that H. polygyrus blocks the IL-33 pathway via both HpARI which blocks the cytokine, and also HpBARI which blocks the receptor.

Verified
Journal Article
Open access
PDF file
TMThomas C. Mules
Thomas C. Mules
FVFrancesco Vacca
Francesco Vacca
ACAlissa Cait
Alissa Cait
BYBibek Yumnam
Bibek Yumnam
ASAlfonso Schmidt
Alfonso Schmidt
SIStephen Inns
Stephen Inns
Infecting humans with controlled doses of small intestinal helminths, such as human hookworm, is proposed as a therapy for the colonic inflammatory disease ulcerative colitis. Strengthening the colonic mucus barrier is a potential mechanism by which small intestinal helminths could treat ulcerative colitis. In this study, we compare C57BL/6 mice infected with the small intestinal helminth Heligmosomoides polygyrus and uninfected controls to investigate changes in colonic mucus. Histology, gene expression, and immunofluorescent analysis demonstrate that this helminth induces goblet cell hyperplasia, and an upregulation of mucin sialylation, and goblet-cell-derived functional proteins resistin-like molecule-beta (RELM-β) and trefoil factors (TFFs), in the colon. Using IL-13 knockout mice, we reveal that these changes are predominantly IL-13-dependent. The assessment of the colonic mucus microbiome demonstrates that H. polygyrus infection increases the abundance of Ruminococcus gnavus, a commensal bacterium capable of utilising sialic acid as an energy source. This study also investigates a human cohort experimentally challenged with human hookworm. It demonstrates that TFF blood levels increase in individuals chronically infected with small intestinal helminths, highlighting a conserved mucus response between humans and mice. Overall, small intestinal helminths modify colonic mucus, highlighting this as a plausible mechanism by which human hookworm therapy could treat ulcerative colitis.

20 March 2023 in Research Square
Verified
Preprint
Open access
PDF file
FVFrancesco Vacca
Francesco Vacca
BLBrittany Lavender
Brittany Lavender
SNSophia-Louise Noble
Sophia-Louise Noble
ACAlissa Cait
Alissa Cait
KMKate Maclean
Kate Maclean
SIStephen Inns
Stephen Inns
The observation that experimental helminth infection can be associated with immunomodulation and suppression of inflammatory diseases at distal tissue sites, has been used as rationale for trialing helminths such as Necator americanus for the treatment of inflammatory disorders in humans. However, the lack of sufficient knowledge of the immunological interplay between human host and parasite in a controlled infection setting limits ongoing clinical intervention studies. In this one-year longitudinal study, healthy volunteers were recruited and infected with N. americanus. Changes in immune responses, microbiome, plasma metabolome and gut physiology were examined over the course of the one-year period. All participants were successfully infected as confirmed by detectable eggs in the feces and adult worms visualized in the intestine. In general, individual variation in immune cells, serum cytokines, fecal microbiome and plasma metabolites were greater than changes induced by the infection. Nevertheless, eosinophils, serum IL-5, and fecal eosinophil degranulation markers transiently increased in the acute phase of infection. In addition, while we observed stability in microbial community composition through the course of infection, we found a difference in the microbial community composition of participants with moderate gastrointestinal symptoms. No significant changes were observed in gut physiology measured using SmartpillTM, except for a decrease in small bowel pH. Untargeted plasma metabolomics analysis of participant plasma over the course of infection revealed enrichment in tryptophan metabolism following infection which was associated with increased CTLA-4 expression on regulatory T cells (TREGS), CRTH2+ T helper 2 cells (TH2) and CCR6+ T helper 9 cells (TH9). In conclusion, hookworm infection is well tolerated and represents an innovative platform for investigating immunomodulatory properties of hookworm infection in a therapeutic clinical setting.

15 March 2023 in medRxiv
Verified
Preprint
Open access
PDF file
FVFrancesco Vacca
Francesco Vacca
BLBrittany Lavender
Brittany Lavender
SNSophia-Louise Noble
Sophia-Louise Noble
ACAlissa Cait
Alissa Cait
KMKate Maclean
Kate Maclean
SIStephen Inns
Stephen Inns
The observation that experimental helminth infection can be associated with immunomodulation and suppression of inflammatory diseases at distal tissue sites, has been used as rationale for trialing helminths such as Necator americanus for the treatment of inflammatory disorders in humans. However, the lack of sufficient knowledge of the immunological interplay between human host and parasite in a controlled infection setting limits ongoing clinical intervention studies. In this one-year longitudinal study, healthy volunteers were recruited and infected with N. americanus . Changes in immune responses, microbiome, plasma metabolome and gut physiology were examined over the course of the one-year period. All participants were successfully infected as confirmed by detectable eggs in the feces and adult worms visualized in the intestine. In general, individual variation in immune cells, serum cytokines, fecal microbiome and plasma metabolites were greater than changes induced by the infection. Nevertheless, eosinophils, serum IL-5, and fecal eosinophil degranulation markers transiently increased in the acute phase of infection. In addition, while we observed stability in microbial community composition through the course of infection, we found a difference in the microbial community composition of participants with moderate gastrointestinal symptoms. No significant changes were observed in gut physiology measured using Smartpill TM , except for a decrease in small bowel pH. Untargeted plasma metabolomics analysis of participant plasma over the course of infection revealed enrichment in tryptophan metabolism following infection which was associated with increased CTLA-4 expression on regulatory T cells (T REGS ), CRTH2 + T helper 2 cells (T H 2) and CCR6 + T helper 9 cells (T H 9). In conclusion, hookworm infection is well tolerated and represents an innovative platform for investigating immunomodulatory properties of hookworm infection in a therapeutic clinical setting. One Sentence Summary: Controlled human hookworm infection changes immune-linked metabolic pathways

1 February 2026 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Verified
Journal Article
Open access
TMThomas C. Mules
Thomas C. Mules
MCMali Camberis
Mali Camberis
BLBrittany Lavender
Brittany Lavender
KMKate Maclean
Kate Maclean
BYBibek Yumnam
Bibek Yumnam
SIStephen Inns
Stephen Inns
This exploratory study using SmartPill technology found that controlled hookworm infection in healthy adults caused a transient drop in duodenal and small-intestinal pH during the acute phase, but no lasting changes in gut motility or transit. The findings, the first of their kind in humans, suggest that the physiological effects of controlled doses of hookworm are subtle and short-lived, offering reassurance for therapeutic trials while highlighting a potential mechanism for symptoms and malabsorption in endemic regions.